These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 9513575

  • 21. Drug interactions and protease inhibitor therapy in the treatment of HIV/AIDS.
    Klaus BD, Grodesky MJ.
    Nurse Pract; 1998 Feb; 23(2):102-4, 106. PubMed ID: 9513221
    [No Abstract] [Full Text] [Related]

  • 22. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R, Chiodo F.
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [Abstract] [Full Text] [Related]

  • 23. Saquinavir/Ritonavir: its evolution and current treatment role.
    O'Brien WA.
    AIDS Read; 2006 Jan; 16(1):38-44; discussion 43. PubMed ID: 16433471
    [Abstract] [Full Text] [Related]

  • 24. Searching for the right dose of ritonavir-saquinavir.
    TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
    [No Abstract] [Full Text] [Related]

  • 25. What they say about: protease inhibitors.
    Posit Aware; 2000 Sep; 11(1):48-54. PubMed ID: 11366351
    [Abstract] [Full Text] [Related]

  • 26. Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy.
    Condra JH, Petropoulos CJ, Ziermann R, Schleif WA, Shivaprakash M, Emini EA.
    J Infect Dis; 2000 Sep; 182(3):758-65. PubMed ID: 10950769
    [Abstract] [Full Text] [Related]

  • 27. Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population.
    Dever LL, Oruwari PA, Figueroa WE, O'Donovan CA, Eng RH.
    Ann Pharmacother; 2000 May; 34(5):580-4. PubMed ID: 10852083
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
    Rudin C, Burri M, Shen Y, Rode R, Nadal D, Pediatric Infectious Disease Group of Switzerland, Swiss Mother and Child HIV Cohort Study (MoCHiV).
    Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
    [Abstract] [Full Text] [Related]

  • 30. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001 May; 12(12):6-7. PubMed ID: 11570094
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F, Adda N, Schneider V, Jacomet C, Salhi Y, Rozenbaum W.
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract] [Full Text] [Related]

  • 36. Risk factors for ritonavir intolerance and outcome after change to indinavir.
    Casado JL, Perez-Elías MJ, Antela A, Martí-Belda P, de Lucas S, Muñoz V, Guerrero A.
    AIDS; 1998 Feb 12; 12(3):335-6. PubMed ID: 9580044
    [No Abstract] [Full Text] [Related]

  • 37. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M.
    J Int Assoc Physicians AIDS Care; 1997 Jun 12; 3(6):17-21. PubMed ID: 11364427
    [Abstract] [Full Text] [Related]

  • 38. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN, Feinberg J, Goodrich J, Pilson RS, Siemon-Hryczyk P.
    Antivir Ther; 2003 Feb 12; 8(1):37-42. PubMed ID: 12713062
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.